عنوان
پدید آورنده
موضوع
رده
RC848.H42 .P69 2004eb
RC848
.
H42
.
P69
2004eb
کتابخانه
محل استقرار
0203357183
9780203357187
1841843695
9781841843698
b786155
Hepatitis C and B :
[Book]
management and treatment /
Thierry Poynard.
2nd ed.
London :
Taylor & Francis,
2004
(2005 printing)
1 online resource (v, 168 pages) :
color illustrations, color maps
"A Martin Dunitz book."
Previous ed. published as: Hepatitis C infection. London : Martin Dunitz, 2000.
Includes bibliographical references and index.
""Book Cover""; ""Title""; ""Copyright""; ""Contents""; ""Introduction""; ""I Hepatitis C""; ""1. Natural History of Hepatitis C: Epidemiology""; ""2. Natural History of Hepatitis C: Hepatic Manifestations""; ""3. Natural of Hepatitis C: Extrahepatic Manifestations and Quality of Life""; ""4. Management Protocols in Chronic Hepatitis C""; ""5. Management of Relapsers and Nonresponders�Maintenance Therapy""; ""6. Management of Patients with Cirrhosis""; ""7. Management of Patients Coinfected by HCV and HIV""; ""8. Management of HCV Infection After Liver Transplantation""
""18. Natural History of Hepatitis B: Hepatic Manifestations""""19. Natural History of Hepatitis B: Extrahepatic Manifestations and Quality of Life""; ""20. Goal of Treatment in Chronic Hepatitis B""; ""21. Efficacy of Interferon and Pegylated Interferon (PEG-IFN)""; ""22. Efficacy of Lamivudine""; ""23. Comparison Between Lamivudine, Interferon and the Combination of Interferon and Lamivudine""; ""24. Safety of Lamivudine""; ""25. Efficacy of Adefovir""; ""26. Safety of Adefovir""; ""27. First-line Treatment of Chronic Hepatitis B: Adefovir, Lamivudine or Interferon?""
""28. New Drugs in Development""""29. Who Needs to be Treated and How to Explain the Goals to the Patient""; ""30. Management of Relapsers and Nonresponders""; ""31. Management of Patients Coinfected by HBV and HIV""; ""32. Management of Transplanted Patients Chronically Infected by HBV""; ""33. Cost-effectiveness of Treatment""; ""References""; ""III Biochemical Markers: An Alternative to Liver Biopsies""; ""34. Needle Biopsy of the Liver: Value and Limitations""; ""35. Advantage and Limits of Biochemical Markers""; ""References""
""9. Management of Patients with Renal Disease""""10. Other Difficult-to-treat Populations""; ""11. Safety of Interferon, Pegylated Interferon (PEG-IFN) and Ribavirin""; ""12. Who Needs to be Treated and How to Explain the Goals to the Patient""; ""13. What is the Cost-effectiveness of Combination Regiments?""; ""14. Management of Acute Hepatitis C""; ""15. Practical Guidelines for the Management of Hepatitis C""; ""16. New Drugs in Development""; ""References""; ""II Hepatitis B""; ""17. Natural History of Hepatitis B: Epidemiology""
0
8
8
8
Provides a practical explanation of the natural history and management of the diseases, and examines the benefits of the most recent drugs, and their effects, whether used in isolation or as part of a combination therapy. This second edition expands the coverage of biochemical markers and of the tgreatment of various difficult-to-treat patients.
Informa Healthcare
9780203357187
Hepatitis C and B.
1841843695
Biochemical markers-- Therapeutic use.
Hepatitis B-- Treatment.
Hepatitis C-- Treatment.
Interferon-- Therapeutic use.
Hepatitis B, Chronic-- complications.
Hepatitis B, Chronic-- drug therapy.
Hepatitis C, Chronic-- complications.
Hepatitis C, Chronic-- drug therapy.
Hépatite B-- Traitement.
Hépatite C-- Traitement.
Hépatite virale.
FOREIGN LANGUAGE STUDY-- Spanish.
Hepatitis C-- Treatment.
Interferon-- Therapeutic use.
FOR-- 026000
616
.
3623061
22
RC848
.
H42
.
P69
2004eb
2004
J-822
WC
536
P892h
2004
Poynard, T., (Thierry)
Poynard, T., (Thierry).
20201206235828.0
pn
مطالعه متن کتاب [Book]
Y
